References
- Jick H, Derby L E, Myers M W, Vasilakis C, Newton K M. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogen. Lancet 1996; 348: 981–983
- Grodstein F, Manson J E, Stampfer M J, Rexrode K. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med 2008; 168: 861–866
- Rossouw J E, Prentice R L, Manson J E, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465–1477
- Stevenson J C. HRT and the primary prevention of cardiovascular disease. Maturitas 2007; 57: 31–34
- Sturdee D W, MacLennan A H. Reducing the problems of the progestogen. Climacteric 2006; 9: 241–243
- Gambacciani M, Genazzani A R. Hormone replacement therapy: the benefits in tailoring the regimen and dose. Maturitas 2001; 40: 195–201
- Notelovitz M, Lenihan J P, McDermott M, Kerber I J, Nanavati N, Arce J-C. Initial 17β-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000; 95: 726–731
- Lindsay R, Gallagher J C, Kleerekoper M, et al. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 2002; 287: 2668–2676
- Pickar J H, Yeh I T, Wheeler J E, Cunnane M F, Speroff L. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results. Fertil Steril 2003; 80: 1234–1240
- Panay N, Ylikorkala O, Archer D F, et al. Ultra-low-dose estradiol and norethisterone acetate: effective menopause symptom relief. Climacteric 2007; 10: 120–131
- Greenwald M W, Gluck O S, Lang E, Rakov V. Oral hormone therapy with 17β-estradiol and 17β-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects. Menopause 2005; 12: 741–748
- Ettinger B, Kristine E, Ensrud E, et al. Effects of ultra low-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 2004; 104: 443–451
- Lobo R A, Bush T, Carr B R, Pickar J H. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 2001; 76: 13–24
- Schlegel W, Petersdorf L I, Junker R, Schulte H, Ebert C, Von Eckardstein A. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women. Clin Endocrinol (Oxf) 1999; 51: 643–651
- Scarabin P-Y, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003; 362: 428–432
- Sanada M, Higashi Y, Nakagawa K, et al. A comparison of low-dose and standard-dose oral estrogen on forearm endothelial function in early postmenopausal women. J Clin Endocrinol Metab 2003; 88: 1303–1309
- Wingrove C S, Garr E, Godsland I F, Stevenson J C. 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1998; 1406: 169–174
- Mercuro G, Vitale C, Fini M, Zoncu S, Leonardo F, Rosano G M. Lipid profiles and endothelial function with low-dose hormone replacement therapy in postmenopausal women at risk for coronary artery disease: a randomized trial. Int J Cardiol 2003; 89: 257–265
- Collins P, Flather M, Lees B, et al. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study. Eur Heart J 2006; 27: 2046–2053
- Harman S M, Brinton E A, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005; 8: 3–12
- Hodis H N, Mack W J. Coronary heart disease and hormone replacement therapy after the menopause. Climacteric 2009; 12(Suppl 1)71–75
- Pines A, Sturdee D W, Birkhäuser M H, Schneider H P, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007; 10: 181–194
- Panay N, Fenton A. HRT: does the dose matter?. Climacteric 2008; 11: 177–178